Anthony L. Zietman

About

Dr. Anthony L. Zietman is a leading authority in radiation oncology, with a career dedicated to advancing the precision and efficacy of prostate cancer treatment. His research primarily focuses on the comparative effectiveness of emerging technologies, including proton therapy and robotic-assisted surgery, and their implications for radiation field design. Dr. Zietman is perhaps best known for his provocative and widely-cited analysis, "Too Big to Fail? The Current Status of Proton Therapy in the USA" (25 citations), which critically examined the economic and clinical sustainability of proton therapy, sparking essential debate within the field. His work also includes pioneering dosimetric validation studies for robotic prostate stereotactic body radiotherapy (SBRT), using advanced 3D-printed models to optimize dose escalation to dominant intraprostatic lesions. Through these contributions, Dr. Zietman has shaped modern clinical practice, challenging the field to balance technological innovation with evidence-based outcomes. His scholarship continues to influence how radiation oncologists approach treatment planning and technology adoption, making him a pivotal voice in the ongoing evolution of prostate cancer care.

Research Focus

Key Achievements

Top Papers

1. 1
   Too Big to Fail? The Current Status of Proton Therapy in the USA

   25 citations · 2017
2. 2
   Anatomic differences after robotic-assisted radical prostatectomy and open prostatectomy: implications for radiation field design

   5 citations · 2011
3. 3
   Dosimetric Validation of Robotic Prostate SBRT With Simultaneous Integrated Dose Escalation to Dominant Intraprostatic Lesion Using a Magnetic Resonance–Based 3D-Printed Prostate Model in an Anthropomorphic Pelvis Phantom

   2 citations · 2016

Key Collaborators

Contact & Links